New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...

SALT LAKE CITY, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will present new data in eight ...

In the 21st century, oncology has achieved extraordinary progress. We can decode a tumor’s genome, tailor therapies to ...

UC San Diego scientists discover enzyme responsible for scrambling cancer genomes; results could enable new treatments for ...

A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK fusion mutation and treat him with targeted therapy instead of chemotherapy.

Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to ...

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...

Daniel Tukey found a clinical trial that knocked out his colorectal cancer.

In the field of cancer research, bioinformatics plays a pivotal role in dissecting the intricate molecular interactions that dictate cancer development and ...

UC San Diego researchers uncover enzyme behind cancer genome chaos, pointing to potential therapies for aggressive tumors.

Researchers studied synthetic lethality pathway using Promega NanoBRET(R) TE technology -- Study is the first to characterize uncompetitive binding directly in live cells, illuminating a mechanistic ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.